Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Celyad Oncology SA
Celyad Oncology announces intention to terminate SEC reporting obligations
February 08, 2024
From
Celyad Oncology SA
Via
GlobeNewswire
Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook
January 16, 2024
From
Celyad Oncology SA
Via
GlobeNewswire
Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)
December 20, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
December 15, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Celyad announces management change
December 04, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)
December 01, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)
November 21, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
November 14, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Celyad Oncology reports third quarter 2023 financial results and recent business highlights
November 09, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Celyad Oncology announces the termination of its American Depository Receipt program
September 25, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Publication of a rectified transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)
September 15, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)
September 12, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)
September 07, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Tickers
CYAD
Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
September 05, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Tickers
CYAD
Celyad Oncology Reports First Half 2023 Financial Results and Recent Business Highlights
September 04, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Tickers
CYAD
Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholders
August 24, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Tickers
CYAD
Celyad Oncology announces receipt of Nasdaq delisting notice
May 15, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Tickers
CYAD
Celyad Oncology Announces Intent to Voluntarily Delist American Depository Shares From Nasdaq
May 05, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Tickers
CYAD
Celyad Oncology reports first quarter 2023 financial results and recent business highlights
May 05, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Tickers
CYAD
Celyad Oncology announces receipt of Nasdaq initial notification on ADS bid price
April 24, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Tickers
CYAD
Celyad Oncology announces receipt of Nasdaq notice
April 04, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Tickers
CYAD
Celyad Oncology appoints Georges Rawadi as its new CEO
March 24, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Tickers
CYAD
Celyad Oncology reports full year 2022 financial results and recent business highlights
March 23, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Tickers
CYAD
Celyad Oncology to announce full year 2022 financial results and host conference call
March 17, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Tickers
CYAD
Celyad Oncology announces non-cash impairment
March 15, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Tickers
CYAD
REPEAT -- Celyad Oncology SA - Letter to Shareholders
March 01, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Tickers
CYAD
Celyad Oncology SA - Letter to Shareholders
February 28, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Tickers
CYAD
Celyad Oncology announces the publication of data from its Phase 1 THINK study of CYAD-01
February 09, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Tickers
CYAD
Celyad Oncology provides fourth quarter 2022 business update and 2023 outlook
February 03, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Tickers
CYAD
Celyad Oncology provides an update on its strategic business model, continuing to focus on opportunities to fully harness the true potential of its proprietary technology platforms and intellectual property
December 21, 2022
From
Celyad Oncology SA
Via
GlobeNewswire
Tickers
CYAD
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.